MYDECINE INNOVATIONS G F's ticker is MYCOF and the CUSIP is 62848R106. A total of 2 filers reported holding MYDECINE INNOVATIONS G F in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOLLENCREST CAPITAL MANAGEMENT | 20,000 | $6,000 | 0.00% |
| American Research & Management Co. | 2,000 | $1,000 | 0.00% |